Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach
Abstract Background In the present study, a new and sensitive UPLC method for stability-indicating study has been established and validated as per the ICH guidelines. To date, no work has been reported on the forced degradation studies of alpelisib using the UPLC technique. Box–Behnken design was us...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-04-01
|
| Series: | Future Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43094-025-00802-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042565491949568 |
|---|---|
| author | Tandrima Majumder Shiva Kumar Gubbiyappa Padmini Iriventi |
| author_facet | Tandrima Majumder Shiva Kumar Gubbiyappa Padmini Iriventi |
| author_sort | Tandrima Majumder |
| collection | DOAJ |
| description | Abstract Background In the present study, a new and sensitive UPLC method for stability-indicating study has been established and validated as per the ICH guidelines. To date, no work has been reported on the forced degradation studies of alpelisib using the UPLC technique. Box–Behnken design was used to study the response surface for method optimisation to achieve a good separation with a minimum number of experimental trials. Three independent parameters selected were mobile phase ratio, flow rate of the mobile phase and temperature of the column. Retention time and tailing factor were taken as two responses to obtain mathematical models. Results The chromatography was executed using Waters BEH C18 UPLC column (2.1 × 50 mm, 1.7micron) at wavelength detection of 246 nm. The optimised assay conditions predicted were isocratic mobile solvent system using 0.1% formic acid buffer solution and acetonitrile in the ratio of 50:50 (V/V), with a flow rate of 0.25 mL per min and injection volume of 4 µL. The method has shown a good response with a total run time of 4 min, retention time was found to be 1.49 min and tailing factor was 0.99 for alpelisib, showing good peak symmetry. The linearity of the method developed is at a range of 10–50 µg/mL with R2 0.9955, while the percentage mean recovery for accuracy was of 99.25%. The method developed was precise as % RSD of inter-day and intra-day precision was 0.3 and 0.1, respectively, meeting the specified limits. Conclusion The developed UPLC work is quick and simple with an increased level of linearity, precision, specificity and accuracy as per the ICH criteria and can find application in industries as a regular method for quantification of alpelisib. |
| format | Article |
| id | doaj-art-68999ad10d8f4c1999941b8d175a2ecf |
| institution | DOAJ |
| issn | 2314-7253 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Future Journal of Pharmaceutical Sciences |
| spelling | doaj-art-68999ad10d8f4c1999941b8d175a2ecf2025-08-20T02:55:31ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532025-04-0111111510.1186/s43094-025-00802-wStability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approachTandrima Majumder0Shiva Kumar Gubbiyappa1Padmini Iriventi2College of Pharmacy, COER UniversitySchool of Pharmacy, GITAM, Deemed to Be UniversityDepartment of Pharmaceutics, MRM College of PharmacyAbstract Background In the present study, a new and sensitive UPLC method for stability-indicating study has been established and validated as per the ICH guidelines. To date, no work has been reported on the forced degradation studies of alpelisib using the UPLC technique. Box–Behnken design was used to study the response surface for method optimisation to achieve a good separation with a minimum number of experimental trials. Three independent parameters selected were mobile phase ratio, flow rate of the mobile phase and temperature of the column. Retention time and tailing factor were taken as two responses to obtain mathematical models. Results The chromatography was executed using Waters BEH C18 UPLC column (2.1 × 50 mm, 1.7micron) at wavelength detection of 246 nm. The optimised assay conditions predicted were isocratic mobile solvent system using 0.1% formic acid buffer solution and acetonitrile in the ratio of 50:50 (V/V), with a flow rate of 0.25 mL per min and injection volume of 4 µL. The method has shown a good response with a total run time of 4 min, retention time was found to be 1.49 min and tailing factor was 0.99 for alpelisib, showing good peak symmetry. The linearity of the method developed is at a range of 10–50 µg/mL with R2 0.9955, while the percentage mean recovery for accuracy was of 99.25%. The method developed was precise as % RSD of inter-day and intra-day precision was 0.3 and 0.1, respectively, meeting the specified limits. Conclusion The developed UPLC work is quick and simple with an increased level of linearity, precision, specificity and accuracy as per the ICH criteria and can find application in industries as a regular method for quantification of alpelisib.https://doi.org/10.1186/s43094-025-00802-wICH guidelinesAlpelisibQbDStability studiesUPLC |
| spellingShingle | Tandrima Majumder Shiva Kumar Gubbiyappa Padmini Iriventi Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach Future Journal of Pharmaceutical Sciences ICH guidelines Alpelisib QbD Stability studies UPLC |
| title | Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach |
| title_full | Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach |
| title_fullStr | Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach |
| title_full_unstemmed | Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach |
| title_short | Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach |
| title_sort | stability indicating uplc method for quantification of alpelisib in bulk and tablet formulation by qbd approach |
| topic | ICH guidelines Alpelisib QbD Stability studies UPLC |
| url | https://doi.org/10.1186/s43094-025-00802-w |
| work_keys_str_mv | AT tandrimamajumder stabilityindicatinguplcmethodforquantificationofalpelisibinbulkandtabletformulationbyqbdapproach AT shivakumargubbiyappa stabilityindicatinguplcmethodforquantificationofalpelisibinbulkandtabletformulationbyqbdapproach AT padminiiriventi stabilityindicatinguplcmethodforquantificationofalpelisibinbulkandtabletformulationbyqbdapproach |